Tradestie Institutional Equity Comparison Engine
GENZ vs MEDI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MEDI Overall Edge
MEDI Captures Institutional Edge (1โ0 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Harbor Health Care ETF (MEDI) driven by superior Momentum & Technical. Fundamentally, GENZ trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MEDI at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, GENZ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MEDI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
GENZ N/M vs MEDI N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
MEDI
1Y +4.0% vs +14.7% ยท 52W Pos 32% vs 90%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GENZ
US Equity
GENZ
Institutional Equity
$36.39
-2.5% 1D
Market Cap
N/A
1M Return
-3.98%
1Y Return
+4.02%
Forward P/E
N/M
Unified AI Score
44.3 / 100
HOLD
Tech 49.0
Fund 50.0
Flow 50.0
Mom 64.0
MEDI
NYSE Arca
Harbor Health Care ETF
Institutional Equity
$35.59
-2.05% 1D
Market Cap
N/A
1M Return
+9.92%
1Y Return
+14.68%
Forward P/E
N/M
Unified AI Score
42.1 / 100
HOLD
Tech 25.0
Fund 39.0
Flow 50.0
Mom 22.2
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
GENZ +4.02%
MEDI +14.68%
Spread: +14.3 pp (MEDI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
GENZ TTM Op. Margin: N/A
MEDI TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GENZ vs MEDI. Trailing 12-month operating profitability (GENZ N/A vs MEDI N/A) and valuation multiples (GENZ N/M vs MEDI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GENZ | MEDI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 32% ($34โ$41) | 90% ($28โ$37) | Stronger Trend | MEDI |
| Beta / 30D Volatility Risk Regime | 0.85ฮฒ ยท 27% Vol | 0.59ฮฒ ยท 22% Vol | Lower Realized Risk | MEDI |
| Unified Institutional Score Composite Signal | 44.3 / 100 (HOLD) | 42.1 / 100 (HOLD) | Higher Composite | GENZ |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full GENZ vs MEDI Buy Guide
GENZ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MEDI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither GENZ nor MEDI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.